Plasma PLUS at the Nottingham Early Career Prostate Cancer Research Symposium
Plasma Plus research group PhD candidate Shengxin Zhang represented the group at the Nottingham Early Career Prostate Cancer Research Symposium (online), held at the University of Nottingham on 15 July 2026.
During the symposium’s three-minute flash-talk session, Shengxin presented her research project, entitled “Exploration of Indane Scaffold Derivatives for Combination Prostate Cancer Therapy with Cold Atmospheric Plasma.”
Her presentation explored the potential of cold atmospheric plasma and plasma-activated water to enhance the anticancer activity of androgen receptor-targeted treatments. The study used clinically approved drug bicalutamide as a reference compound before extending the combination strategy to selected indane scaffold derivatives. The findings also indicated that plasma-derived reactive oxygen and nitrogen species may contribute to the enhanced treatment response.
The symposium brought together early-career researchers, clinicians and people with lived experience of prostate cancer to share research developments and promote multidisciplinary collaboration.
We thank Professor Nigel Mongan and the organizing team for the opportunity to participate and present our research.
